DJIA 17,057.59 78.46 0.46%
NASDAQ 4,525.51 -0.98 -0.02%
S&P 500 1,992.13 5.62 0.28%
market minute promo

Nektar Therapeutics (NASDAQ: NKTR)



company name or ticker

Nektar Therapeutics Harnesses The Power Of AstraZeneca To Move Movantik

Nektar President Howard Robin Is Listening To You

Nektar's Loss Narrows in Q2, Beats Revenues, Retains View - Analyst Blog

Nektar's Loss Narrows in Q2, Beats Revenues, Retains View - Analyst Blog

Nektar Therapeutics' (NKTR) CEO Howard Robin on Q2 2014 Results - Earnings Call Transcript

Nektar: Reason Will Rarely Fail You

Nektar Therapeutics (NKTR): New Analyst Report from Zacks Equity Research - Zacks Equity Research Re

Nektar Therapeutics (NKTR): New Analyst Report from Zacks Equity Research - Zacks Equity Research Report

Can Anything Derail Salix Pharmaceuticals?

Expanded labeling for the sub-q form of Relistor could add $100 million in revenue, but doesn't change the business to a large extent

Why GW Pharmaceuticals Could be the Next Marijuana Bubble Stock to Pop

Shares of GW Pharmaceuticals have more than doubled in the last year.

AstraZeneca's Naloxegol Data Published - Analyst Blog

Regado Biosciences: The Revolyxis Revolution Has Begun

See More Articles...